In a randomised, controlled, single-blind trial in the UK, patients in the 'active' group received needling at Zanzhu BL-2, Yingxiang L.I.-20 and Hegu L.I.-4 (deqi was obtained and needles retained for five minutes), whilst...

    • Please note: The rest of this article is only available to subscribers of the Journal of Chinese medicine. Please subscribe now.

Categories: Hay fever

Not yet subscribed?

Subscribe to the Journal of Chinese Medicine now from only £30.00 per year. Your subscription will include:

Subscribe now